We are live on ! Find out more

Core Laboratories

CLB

Market cap $574M

12.50 USD

-0.03

0.24%

At close Updated Sep 11, 4:00 PM EDT

Pre-market

After hours

12.50

0.00

0%

1 day

-0.24%

5 days

1.38%

1 month

0.56%

3 months

-5.66%

6 months

-23.87%

Year to date

-26.25%

1 year

-1.34%

5 years

-56.58%

10 years

-88.68%

About: Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.

Employees: 3,300

Energy Oil & Gas Equipment & Services

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 25%

Neutral 50%

Negative 25%

Zacks Investment Research

3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges

Strict capital discipline by upstream energy companies is acting as a dampener, making the outlook for the Zacks Oil and Gas-Field Services industry gloomy. FTI, OII and CLB are expected to survive the industry woes.

3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges

Zacks Investment Research

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

DTI or CLB: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Oil and Gas - Field Services sector might want to consider either Drilling Tools International Corp. (DTI) or Core Laboratories (CLB). But which of these two stocks is more attractive to value investors?

DTI or CLB: Which Is the Better Value Stock Right Now?

Zacks Investment Research

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Zacks Investment Research

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength offsets Reservoir Description weakness.

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

Core Laboratories Q2 Earnings Call Highlights

Core Laboratories NYSE: CLB reported second-quarter 2026 revenue of $124.6 million, up more than 2% from the prior quarter but down 4% from a year earlier, as stronger completion-product sales partly offset disruptions to its service business from conflicts in the Middle East and Russia-Ukraine.

Core Laboratories Q2 Earnings Call Highlights

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Core Laboratories (CLB) Q2 Earnings Surpass Estimates

Core Laboratories (CLB) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.19 per share a year ago.

Core Laboratories (CLB) Q2 Earnings Surpass Estimates

CORE LAB REPORTS SECOND QUARTER 2026 RESULTS

REVENUE OF $ 124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR OPERATING INCOME OF $ 9.2 MILLION; EX-ITEMS, $9.4 MILLION, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR GAAP EARNINGS PER SHARE OF $0.13; EPS EX-ITEMS OF $0.11, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR FREE CASH FLOW OF $ 3.1 MILLION COMPANY REPURCHASED 214,712 SHARES OF COMMON STOCK, FOR $2.7 MILLION AGGREGATE PURCHASE PRICE COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND HOUSTON, July 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported second quarter 2026 revenue of $124,600,000. Core's operating income was $9,200,000, with earnings per diluted share ("EPS") of $0.13, all in accordance with U.S. generally accepted accounting principles ("GAAP").

CORE LAB REPORTS SECOND QUARTER 2026 RESULTS

Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity

The Ariel Small/Mid Cap Value Composite rose +15.08% gross of fees (+14.95% net of fees) in the quarter, falling short of both the Russell 2500 Value Index's +18.50% return and the +20.26% gain posted by the Russell 2500 Index. Live entertainment, media, and technology company, Sphere Entertainment Co. was the top contributor during the quarter on solid earnings and improving operating fundamentals. Shares of Prestige Consumer Healthcare moved lower following disappointing earnings, driven primarily by ongoing supply constraints in its eye care segment and extended lead times in the Middle East.

Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity

See News Rankings

Price charts implemented using Lightweight Charts™